Sanjay Keswani

EVP & Chief Medical Officer, Annexon, Inc.

Companies

Neurocrine BiosciencesChief Medical Officer Jun 4, 2025 to now¹
Annexon, Inc.EVP & Chief Medical Officer Jul 23, 2020 to Feb 15, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Neurocrine Biosciences NBIX3,281 shares³$450.7K at $137.36Sep 11, 2026
Annexon, Inc. ANNX12,500 shares⁴$48.4K at $3.87Feb 11, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 11, 2026Shares withheld for tax 2,112 shares at $156.22 of Neurocrine Biosciences³
Sep 11, 2026Granted 3,914 shares of Neurocrine Biosciences³
Jun 2, 2026Shares withheld for tax 1,733 shares at $154.84 of Neurocrine Biosciences⁵
Jun 2, 2026Exercised options 3,212 shares of Neurocrine Biosciences⁵
Feb 11, 2022Granted 12,500 shares of Annexon, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNeurocrine Biosciences, Chief Medical Officer
2
SEC EDGARAnnexon, Inc., EVP & Chief Medical Officer
3
SEC EDGARNeurocrine Biosciences shares after the filing of Sep 11, 2026
4
SEC EDGARAnnexon, Inc. shares after the filing of Feb 11, 2022
5
SEC EDGARForm 4 filed Jun 4, 2026